APO RESEARCH · REPORT
Divalproex Sodium
Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures.
Product & engineering
Understand the product.
Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures.
Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches.
This medicine is available only with your doctor's prescription.
Selected research
Industry Research
Divalproex Sodium Industry Research Report 2026
Market perspective
Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures.
Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches.
This medicine is available only with your doctor's prescription.
Read the full market overview
North America is the largest market with about 41% market share. Europe is follower, accounting for about 26% market share.
The key players are AbbVie, Mylan, Zydus Pharms USA, Aurobindo Pharma, Dr Reddys Labs, LUPIN, Orchid, Sun Pharm, Teva etc. Top 3 companies occupied about 49% market share.
Report Scope
This report quantifies the global Divalproex Sodium market in terms of revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Divalproex Sodium Market by Company
AbbVie
Mylan
Zydus Pharms USA
Aurobindo Pharma
Dr Reddys Labs
LUPIN
Orchid
Sun Pharm
Teva
Divalproex Sodium Segment by Type
Tablet
Capsule
Others
Divalproex Sodium Segment by Application
Epilepsy
Manic-depressive Illness
Others
Divalproex Sodium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Divalproex Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Divalproex Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Divalproex Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Divalproex Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Divalproex Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Divalproex Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Capsule
- Others
Applications
- Epilepsy
- Manic-depressive Illness
- Others
Companies covered
- AbbVie
- Mylan
- Zydus Pharms USA
- Aurobindo Pharma
- Dr Reddys Labs
- LUPIN
- Orchid
- Sun Pharm
- Teva
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Divalproex Sodium Market Size (2021-2032)
- 2.2.2 Global Divalproex Sodium Sales (2021-2032)
- 2.2.3 Global Divalproex Sodium Market Average Price (2021-2032)
- 2.3 Divalproex Sodium by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Capsule
- 2.3.4 Others
- 2.4 Divalproex Sodium by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Epilepsy
- 2.4.3 Manic-depressive Illness
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Divalproex Sodium Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Divalproex Sodium Sales (MT) of Manufacturers (2021-2026)
- 3.3 Global Divalproex Sodium Revenue of Manufacturers (2021-2026)
- 3.4 Global Divalproex Sodium Average Price by Manufacturers (2021-2026)
- 3.5 Global Divalproex Sodium Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Divalproex Sodium, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Divalproex Sodium, Product Type & Application
- 3.8 Global Manufacturers of Divalproex Sodium, Established Date
- 3.9 Global Divalproex Sodium Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AbbVie
- 4.1.1 AbbVie Company Information
- 4.1.2 AbbVie Business Overview
- 4.1.3 AbbVie Divalproex Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AbbVie Divalproex Sodium Product Portfolio
- 4.1.5 AbbVie Recent Developments
- 4.2 Mylan
- 4.2.1 Mylan Company Information
- 4.2.2 Mylan Business Overview
- 4.2.3 Mylan Divalproex Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mylan Divalproex Sodium Product Portfolio
- 4.2.5 Mylan Recent Developments
- 4.3 Zydus Pharms USA
- 4.3.1 Zydus Pharms USA Company Information
- 4.3.2 Zydus Pharms USA Business Overview
- 4.3.3 Zydus Pharms USA Divalproex Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Zydus Pharms USA Divalproex Sodium Product Portfolio
- 4.3.5 Zydus Pharms USA Recent Developments
- 4.4 Aurobindo Pharma
- 4.4.1 Aurobindo Pharma Company Information
- 4.4.2 Aurobindo Pharma Business Overview
- 4.4.3 Aurobindo Pharma Divalproex Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Aurobindo Pharma Divalproex Sodium Product Portfolio
- 4.4.5 Aurobindo Pharma Recent Developments
- 4.5 Dr Reddys Labs
- 4.5.1 Dr Reddys Labs Company Information
- 4.5.2 Dr Reddys Labs Business Overview
- 4.5.3 Dr Reddys Labs Divalproex Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Dr Reddys Labs Divalproex Sodium Product Portfolio
- 4.5.5 Dr Reddys Labs Recent Developments
- 4.6 LUPIN
- 4.6.1 LUPIN Company Information
- 4.6.2 LUPIN Business Overview
- 4.6.3 LUPIN Divalproex Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 LUPIN Divalproex Sodium Product Portfolio
- 4.6.5 LUPIN Recent Developments
- 4.7 Orchid
- 4.7.1 Orchid Company Information
- 4.7.2 Orchid Business Overview
- 4.7.3 Orchid Divalproex Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Orchid Divalproex Sodium Product Portfolio
- 4.7.5 Orchid Recent Developments
- 4.8 Sun Pharm
- 4.8.1 Sun Pharm Company Information
- 4.8.2 Sun Pharm Business Overview
- 4.8.3 Sun Pharm Divalproex Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sun Pharm Divalproex Sodium Product Portfolio
- 4.8.5 Sun Pharm Recent Developments
- 4.9 Teva
- 4.9.1 Teva Company Information
- 4.9.2 Teva Business Overview
- 4.9.3 Teva Divalproex Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Teva Divalproex Sodium Product Portfolio
- 4.9.5 Teva Recent Developments
5 Global Divalproex Sodium Market Scenario by Region
- 5.1 Global Divalproex Sodium Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Divalproex Sodium Sales by Region: 2021-2032
- 5.2.1 Global Divalproex Sodium Sales by Region: 2021-2026
- 5.2.2 Global Divalproex Sodium Sales by Region: 2027-2032
- 5.3 Global Divalproex Sodium Revenue by Region: 2021-2032
- 5.3.1 Global Divalproex Sodium Revenue by Region: 2021-2026
- 5.3.2 Global Divalproex Sodium Revenue by Region: 2027-2032
- 5.4 North America Divalproex Sodium Market Facts & Figures by Country
- 5.4.1 North America Divalproex Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Divalproex Sodium Sales by Country (2021-2032)
- 5.4.3 North America Divalproex Sodium Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Divalproex Sodium Market Facts & Figures by Country
- 5.5.1 Europe Divalproex Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Divalproex Sodium Sales by Country (2021-2032)
- 5.5.3 Europe Divalproex Sodium Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Divalproex Sodium Market Facts & Figures by Country
- 5.6.1 Asia Pacific Divalproex Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Divalproex Sodium Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Divalproex Sodium Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Divalproex Sodium Market Facts & Figures by Country
- 5.7.1 South America Divalproex Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Divalproex Sodium Sales by Country (2021-2032)
- 5.7.3 South America Divalproex Sodium Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Divalproex Sodium Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Divalproex Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Divalproex Sodium Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Divalproex Sodium Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Divalproex Sodium Sales by Type (2021-2032)
- 6.1.1 Global Divalproex Sodium Sales by Type (2021-2032) & (MT)
- 6.1.2 Global Divalproex Sodium Sales Market Share by Type (2021-2032)
- 6.2 Global Divalproex Sodium Revenue by Type (2021-2032)
- 6.2.1 Global Divalproex Sodium Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Divalproex Sodium Revenue Market Share by Type (2021-2032)
- 6.3 Global Divalproex Sodium Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Divalproex Sodium Sales by Application (2021-2032)
- 7.1.1 Global Divalproex Sodium Sales by Application (2021-2032) & (MT)
- 7.1.2 Global Divalproex Sodium Sales Market Share by Application (2021-2032)
- 7.2 Global Divalproex Sodium Revenue by Application (2021-2032)
- 7.2.1 Global Divalproex Sodium Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Divalproex Sodium Revenue Market Share by Application (2021-2032)
- 7.3 Global Divalproex Sodium Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Divalproex Sodium Value Chain Analysis
- 8.1.1 Divalproex Sodium Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Divalproex Sodium Production Mode & Process
- 8.2 Divalproex Sodium Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Divalproex Sodium Distributors
- 8.2.3 Divalproex Sodium Customers
9 Global Divalproex Sodium Analyzing Market Dynamics
- 9.1 Divalproex Sodium Industry Trends
- 9.2 Divalproex Sodium Industry Drivers
- 9.3 Divalproex Sodium Industry Opportunities and Challenges
- 9.4 Divalproex Sodium Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst